https://www.mangaloremirror.com/novaremed-enters-into-an-exclusive-option-and-license-agreement-with-neurofront-for-the-non-opioid-neuropathic-pain-treatment-nrd-e1-for-greater-china-and-singapore/
Novaremed Enters Into an Exclusive Option and License Agreement With NeuroFront for the Non-opioid Neuropathic Pain Treatment, NRD.E1, for Greater China and Singapore